Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models

International Journal of Molecular Sciences(2023)10.3390/ijms241813742Source: DataRank Database

Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.81)OA: goldTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Armin Tavakkoli ORCID,Alireza Kheirollah ORCID,Haille E. Soderholm,Eugene Demidenko ORCID,J. Louise Lines ORCID

Live enrichment

PubMed:37762046 PMC:PMC10530750 OpenAlex:https://openalex.org/W4386483634

Dartmouth Cancer Center

Grant: U01CA260446

NCI NIH HHS

Grant: P30 CA023108

NHLBI NIH HHS

Grant: R01 HL155114

FWCI

0.81

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/24/18/13742/pdf?version=1693991549

publisherhttps://www.mdpi.com/1422-0067/24/18/13742/pdf?version=1693991549

publisherhttps://www.mdpi.com/1422-0067/24/18/13742/pdf

journalhttps://doi.org/10.3390/ijms241813742

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37762046

Fields of Study

Cancer Immunotherapy and BiomarkersImmune Cell Function and InteractionImmunotherapy and Immune ResponsesAnimalsMiceAdenocarcinomaAntibodiesDisease Models, AnimalMelanomaT-LymphocytesImmune Checkpoint InhibitorsMembrane Proteins

MeSH Terms

Immune Checkpoint InhibitorsAdenocarcinomaAnimalsAntibodiesDisease Models, AnimalMelanomaMembrane ProteinsT-LymphocytesMice

Keywords

Immune systemCancer researchImmune checkpointBlockadeMelanomaApoptosisRadiation therapyAntibodyBlocking antibodyImmunotherapyBiologyMedicineImmunologyReceptorInternal medicineGeneticsVistaCheckpoint Inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being

Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models

FAIR Checklist

Authors (12)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)